Search - tctmd.com

Displaying 41 - 60 of 137

Sort: Relevancy | Date

News Industry News

STENTYS Stent continues to show low mortality two years after treatment of a heart attack

September 16, 2014

News Industry News

Clinical Trial Results for Impella RP Right Ventricular Heart Failure Trial, RECOVER RIGHT, Released at TCT 2014

September 16, 2014

News Industry News

New Study Examines the Optimal Duration Time of Dual Anti-Platelet Therapy in Patients with Second-Generation Drug-Eluting Stents

September 15, 2014

News Industry News

Large Study Offers Real World Comparison of Blood Thinner Use in Heart Attack Patients

September 15, 2014

News Industry News

Extended Follow-Up of Multicenter Trial Demonstrates Continued Superiority of Bivalirudin to Heparin with and without Glycoprotein IIB, IIIA Inhibition in Patients with Acute Myocardial Infarction

September 15, 2014

News Industry News

New clinical trial results for Miracor’s PICSO® Impulse System in Acute Myocardial Infarction will be reported at ‘TCT 2014’

September 09, 2014

News Industry News

STENTYS Reaches 10,000 Self-Apposing Stent Implantations

September 03, 2014

News Industry News

New Clinical Trial Results Demonstrate Importance of St. Jude Medical Fractional Flow Reserve in Guiding Treatment of NSTEMI Patients

September 01, 2014

News Industry News

Amgen Announces Positive Top-Line Results From Phase 3 YUKAWA-2 Trial Of Evolocumab In Combination With Statins In Japanese Patients With High Cardiovascular Risk And High Cholesterol

August 28, 2014

News Industry News

Medtronic Announces First Implants in Largest-Ever, Global Trial of Cardiac Resynchronization Therapy

August 27, 2014

News Industry News

STENTYS Reallocates Resources to focus on its Advanced Drug-Eluting Stent Program

July 31, 2014

News Industry News

Efficacy and Safety Profile of Pradaxa® (dabigatran etexilate) Repeatedly Confirmed

July 23, 2014

News Industry News

Miracor Medical Systems begins European launch of its next-generation PICSO® Impulse System

July 22, 2014

News Industry News

The Medicines Company Receives Market Authorization Renewal for Angiox® (Bivalirudin) from the European Medicines Agency and the European Commission

July 07, 2014

News Industry News

OrbusNeich Announces First Patient Enrollment in Physician-Initiated Study to Evaluate the Potential for Shorter-Term Dual Antiplatelet Therapy in ACS Patients

June 19, 2014

News Industry News

First Patient Enrolled in PROSPECT II Clinical Trial

June 13, 2014

News Industry News

GSK announces start of phase III cardiovascular outcomes study with losmapimod in patients with acute coronary syndrome

June 05, 2014

News Industry News

STENTYS to Acquire Stent Delivery Technology for Its Next-Generation of Self-Apposing Stents

June 04, 2014

News Industry News

STENTYS Self-Apposing Stent Featured Prominently at 2014 EuroPCR Conference

May 27, 2014

News Industry News

Data on Angiox (Bivalirudin Injection) in Heart Attack Patients Presented at EuroPCR and Published in European Heart Journal

May 22, 2014

Advertisement

STENTYS Stent continues to show low mortality two years after treatment of a heart attack

Clinical Trial Results for Impella RP Right Ventricular Heart Failure Trial, RECOVER RIGHT, Released at TCT 2014

New Study Examines the Optimal Duration Time of Dual Anti-Platelet Therapy in Patients with Second-Generation Drug-Eluting Stents

Large Study Offers Real World Comparison of Blood Thinner Use in Heart Attack Patients

Extended Follow-Up of Multicenter Trial Demonstrates Continued Superiority of Bivalirudin to Heparin with and without Glycoprotein IIB, IIIA Inhibition in Patients with Acute Myocardial Infarction

New clinical trial results for Miracor’s PICSO® Impulse System in Acute Myocardial Infarction will be reported at ‘TCT 2014’

STENTYS Reaches 10,000 Self-Apposing Stent Implantations

New Clinical Trial Results Demonstrate Importance of St. Jude Medical Fractional Flow Reserve in Guiding Treatment of NSTEMI Patients

Amgen Announces Positive Top-Line Results From Phase 3 YUKAWA-2 Trial Of Evolocumab In Combination With Statins In Japanese Patients With High Cardiovascular Risk And High Cholesterol

Medtronic Announces First Implants in Largest-Ever, Global Trial of Cardiac Resynchronization Therapy

STENTYS Reallocates Resources to focus on its Advanced Drug-Eluting Stent Program

Efficacy and Safety Profile of Pradaxa® (dabigatran etexilate) Repeatedly Confirmed

Miracor Medical Systems begins European launch of its next-generation PICSO® Impulse System

The Medicines Company Receives Market Authorization Renewal for Angiox® (Bivalirudin) from the European Medicines Agency and the European Commission

OrbusNeich Announces First Patient Enrollment in Physician-Initiated Study to Evaluate the Potential for Shorter-Term Dual Antiplatelet Therapy in ACS Patients

First Patient Enrolled in PROSPECT II Clinical Trial

GSK announces start of phase III cardiovascular outcomes study with losmapimod in patients with acute coronary syndrome

STENTYS to Acquire Stent Delivery Technology for Its Next-Generation of Self-Apposing Stents

STENTYS Self-Apposing Stent Featured Prominently at 2014 EuroPCR Conference

Data on Angiox (Bivalirudin Injection) in Heart Attack Patients Presented at EuroPCR and Published in European Heart Journal

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content